{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T04:40:10Z","timestamp":1792644010385,"version":"4.5.0"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002383","name":"King Saud University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002383","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012190","name":"Ministry of Science and Higher Education of the Russian Federation","doi-asserted-by":"publisher","award":["075-15-2024-548"],"award-info":[{"award-number":["075-15-2024-548"]}],"id":[{"id":"10.13039\/501100012190","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.ejmech.2026.119324","type":"journal-article","created":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T15:07:44Z","timestamp":1789139264000},"page":"119324","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Discovery of 1,4-diaryl-1,3-dihydro-2H-imidazole-2-thione anticonvulsants integrating AMPA receptor antagonism, Nav1.2 channel blockade, redox modulation, and favorable pharmacokinetic properties"],"prefix":"10.1016","volume":"320","author":[{"given":"Shahenda","family":"Mahmoud","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarek F.","family":"El-Moselhy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eman A.","family":"El-Bastawissy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7847-4690","authenticated-orcid":false,"given":"Nesma M.E.","family":"Abo El Nasr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marawan A.","family":"Elbaset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud A.A.","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahzeb","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarad","family":"Abalkhail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oleg I.","family":"Barygin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arseniy S.","family":"Zhigulin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-8206-8262","authenticated-orcid":false,"given":"Vitalina V.","family":"Furman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana V.","family":"Karelina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald W.","family":"Zamponi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2579-6351","authenticated-orcid":false,"given":"Peter A.","family":"Sidhom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2026.119324_bib1","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.eplepsyres.2017.11.015","article-title":"The new definition and classification of seizures and epilepsy","volume":"139","author":"Falco-Walter","year":"2018","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.ejmech.2026.119324_bib2","author":"Organization"},{"key":"10.1016\/j.ejmech.2026.119324_bib3","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.seizure.2018.02.002","article-title":"Epidemiological profile of epilepsy in low income populations","volume":"56","author":"Espinosa-Jovel","year":"2018","journal-title":"Seizure"},{"issue":"9","key":"10.1016\/j.ejmech.2026.119324_bib4","doi-asserted-by":"crossref","first-page":"4035","DOI":"10.3390\/ijms26094035","article-title":"Antiepileptic drug combinations for epilepsy: mechanisms, clinical strategies, and future prospects","volume":"26","author":"Li","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2026.119324_bib5","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1111\/j.1528-1157.1987.tb05768.x","article-title":"Hepatic considerations in the use of antiepileptic drugs","volume":"28","author":"Dreifuss","year":"1987","journal-title":"Epilepsia"},{"key":"10.1016\/j.ejmech.2026.119324_bib6","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1111\/j.1528-1157.1994.tb05952.x","article-title":"Teratogenic effects of antiepileptic drugs: implications for the management of epilepsy in women of childbearing age","volume":"35","author":"Lindhout","year":"1994","journal-title":"Epilepsia"},{"key":"10.1016\/j.ejmech.2026.119324_bib7","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1034\/j.1600-0404.108.s180.4.x","article-title":"Epilepsy, antiepileptic drugs (AEDs) and cognition","volume":"108","author":"Hirsch","year":"2003","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.ejmech.2026.119324_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.107966","article-title":"Mechanisms of action of currently used antiseizure drugs","volume":"168","author":"Sills","year":"2020","journal-title":"Neuropharmacology"},{"issue":"4","key":"10.1016\/j.ejmech.2026.119324_bib9","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1177\/09727531231185991","article-title":"Recent progress in the development of new antiepileptic drugs with novel targets","volume":"30","author":"Belete","year":"2023","journal-title":"Ann. Neurosci."},{"key":"10.1016\/j.ejmech.2026.119324_bib10","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/ane.12099","article-title":"AMPA receptors as a molecular target in epilepsy therapy","volume":"127","author":"Rogawski","year":"2013","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.ejmech.2026.119324_bib11","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2147\/JRLCR.S51475","article-title":"The AMPA receptor as a therapeutic target in epilepsy: preclinical and clinical evidence","author":"Hanada","year":"2014","journal-title":"J. Recept. Ligand Channel Res."},{"issue":"5","key":"10.1016\/j.ejmech.2026.119324_bib12","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1080\/14737175.2018.1465410","article-title":"Oxidative stress in epilepsy","volume":"18","author":"Geronzi","year":"2018","journal-title":"Expert Rev. Neurother."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119324_bib13","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3390\/antiox11010157","article-title":"The interconnected mechanisms of oxidative stress and neuroinflammation in epilepsy","volume":"11","author":"Parsons","year":"2022","journal-title":"Antioxidants"},{"issue":"10","key":"10.1016\/j.ejmech.2026.119324_bib14","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.3390\/antiox13101172","article-title":"Modulatory impact of oxidative stress on action potentials in pathophysiological states: a comprehensive review","volume":"13","author":"Mahapatra","year":"2024","journal-title":"Antioxidants"},{"issue":"5","key":"10.1016\/j.ejmech.2026.119324_bib15","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.3390\/antiox12051049","article-title":"Oxidative stress and neurodegeneration in animal models of seizures and epilepsy","volume":"12","author":"\u0141ukawski","year":"2023","journal-title":"Antioxidants"},{"issue":"9","key":"10.1016\/j.ejmech.2026.119324_bib16","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1080\/17425255.2021.1959912","article-title":"Understanding mechanisms of drug resistance in epilepsy and strategies for overcoming it","volume":"17","author":"\u0141ukawski","year":"2021","journal-title":"Expert Opin. Drug Metabol. Toxicol."},{"issue":"5","key":"10.1016\/j.ejmech.2026.119324_bib17","doi-asserted-by":"crossref","first-page":"784","DOI":"10.3390\/brainsci13050784","article-title":"Therapeutic strategies to ameliorate neuronal damage in epilepsy by regulating oxidative stress, mitochondrial dysfunction, and neuroinflammation","volume":"13","author":"Madireddy","year":"2023","journal-title":"Brain Sci."},{"issue":"3","key":"10.1016\/j.ejmech.2026.119324_bib18","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.3390\/molecules28031057","article-title":"Structural features of small molecule antioxidants and strategic modifications to improve potential bioactivity","volume":"28","author":"Charlton","year":"2023","journal-title":"Molecules"},{"issue":"4","key":"10.1016\/j.ejmech.2026.119324_bib19","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/j.1528-1167.2011.03024.x","article-title":"Modern antiepileptic drug development has failed to deliver: ways out of the current dilemma","volume":"52","author":"L\u00f6scher","year":"2011","journal-title":"Epilepsia"},{"issue":"5","key":"10.1016\/j.ejmech.2026.119324_bib20","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.seizure.2011.01.003","article-title":"Critical review of current animal models of seizures and epilepsy used in the discovery and development of new antiepileptic drugs","volume":"20","author":"L\u00f6scher","year":"2011","journal-title":"Seizure"},{"issue":"3","key":"10.1016\/j.ejmech.2026.119324_bib21","article-title":"Forecasting an emergent systemic trend in neuropharmacology","volume":"66","author":"Margineanu","year":"2021","journal-title":"Stud. Univ. Babes-Bolyai, Chem."},{"issue":"2","key":"10.1016\/j.ejmech.2026.119324_bib22","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1124\/jpet.108.143420","article-title":"Challenges in the search for drugs to treat central nervous system disorders","volume":"329","author":"Enna","year":"2009","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejmech.2026.119324_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biosystems.2015.11.010","article-title":"Neuropharmacology beyond Reductionism\u2013A likely prospect","volume":"141","author":"Margineanu","year":"2016","journal-title":"Biosystems"},{"issue":"1","key":"10.1016\/j.ejmech.2026.119324_bib24","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1021\/jm970327j","article-title":"Synthesis, anticonvulsant activity, and structure\u2212 activity relationships of sodium channel blocking 3-aminopyrroles","volume":"41","author":"Unverferth","year":"1998","journal-title":"J. Med. Chem."},{"issue":"9","key":"10.1016\/j.ejmech.2026.119324_bib25","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.201700146","article-title":"Design, synthesis, and docking study of pyrimidine\u2013triazine hybrids for GABA estimation in animal epilepsy models","volume":"350","author":"Sahu","year":"2017","journal-title":"Arch. Pharmazie"},{"issue":"2","key":"10.1016\/j.ejmech.2026.119324_bib26","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1021\/ci025625q","article-title":"Pharmacophore modeling as an efficient tool in the discovery of novel noncompetitive AMPA receptor antagonists","volume":"43","author":"Barreca","year":"2003","journal-title":"J. Chem. Inf. Comput. Sci."},{"key":"10.1016\/j.ejmech.2026.119324_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2026.110359","article-title":"Design and optimization of nafimidone-inspired hybrid scaffolds targeting NaV1.2 for antiepileptic therapy with reduced cardiac liability","author":"Mahmoud","year":"2026","journal-title":"Bioorg. Chem."},{"issue":"24","key":"10.1016\/j.ejmech.2026.119324_bib28","doi-asserted-by":"crossref","first-page":"7160","DOI":"10.1016\/j.bmc.2012.09.050","article-title":"Synthesis and SAR study of 4, 5-diaryl-1H-imidazole-2 (3H)-thione derivatives, as potent 15-lipoxygenase inhibitors","volume":"20","author":"Assadieskandar","year":"2012","journal-title":"Bioorg. Med. Chem."},{"issue":"3","key":"10.1016\/j.ejmech.2026.119324_bib29","doi-asserted-by":"crossref","first-page":"767","DOI":"10.3390\/molecules27030767","article-title":"Design, synthesis, molecular docking, and evaluation antioxidant and antimicrobial activities for novel 3-phenylimidazolidin-4-one and 2-aminothiazol-4-one derivatives","volume":"27","author":"Shehab","year":"2022","journal-title":"Molecules"},{"issue":"20","key":"10.1016\/j.ejmech.2026.119324_bib30","doi-asserted-by":"crossref","first-page":"5460","DOI":"10.1016\/j.bmcl.2008.09.036","article-title":"2, 4 (5)-Diarylimidazoles: synthesis and biological evaluation of a new class of sodium channel blockers against hNav1. 2","volume":"18","author":"Rivara","year":"2008","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2026.119324_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104020","article-title":"Design, synthesis and anticonvulsant activity of new imidazolidindione and imidazole derivatives","volume":"101","author":"Marzouk","year":"2020","journal-title":"Bioorg. Chem."},{"issue":"34","key":"10.1016\/j.ejmech.2026.119324_bib32","doi-asserted-by":"crossref","first-page":"9069","DOI":"10.1002\/slct.202102398","article-title":"Thione derivatives as medicinally important compounds","volume":"6","author":"Das","year":"2021","journal-title":"ChemistrySelect"},{"issue":"9","key":"10.1016\/j.ejmech.2026.119324_bib33","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1016\/0006-2952(87)90110-9","article-title":"Antioxidant properties of 2-imidazolones and 2-imidazolthiones","volume":"36","author":"Smith","year":"1987","journal-title":"Biochem. Pharmacol."},{"issue":"3","key":"10.1016\/j.ejmech.2026.119324_bib34","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.arabjc.2016.12.003","article-title":"Hepatotoxicity and antioxidant activity of some new N, N\u2032-disubstituted benzimidazole-2-thiones, radical scavenging mechanism and structure-activity relationship","volume":"11","author":"Anastassova","year":"2018","journal-title":"Arab. J. Chem."},{"key":"10.1016\/j.ejmech.2026.119324_bib35","article-title":"Development of novel imidazole-2-one\/-2-thione heterocyclic derivatives as antimicrobial and antiproliferative agents and evaluation through biological studies and molecular modeling simulations","volume":"1324","author":"Abdullah","year":"2025","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.ejmech.2026.119324_bib36","doi-asserted-by":"crossref","first-page":"8785","DOI":"10.1007\/s11164-015-1928-2","article-title":"An efficient synthesis of pyrrolo [2, 1-a] isoquinoline derivatives containing coumarin skeletons via a one-pot, three-component reaction","volume":"41","author":"Alizadeh","year":"2015","journal-title":"Res. Chem. Intermed."},{"issue":"50","key":"10.1016\/j.ejmech.2026.119324_bib37","doi-asserted-by":"crossref","first-page":"13324","DOI":"10.1002\/anie.201306416","article-title":"Copper-mediated synthesis of 1, 2, 3-triazoles from N-tosylhydrazones and anilines","volume":"52","author":"Chen","year":"2013","journal-title":"Angew. Chem. Int. Ed."},{"issue":"12","key":"10.1016\/j.ejmech.2026.119324_bib38","doi-asserted-by":"crossref","first-page":"6075","DOI":"10.1016\/j.ejmech.2011.10.030","article-title":"Synthesis and kinetic testing of new inhibitors for a metallo-\u03b2-lactamase from Klebsiella pneumonia and Pseudomonas aeruginosa","volume":"46","author":"Mohamed","year":"2011","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119324_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106872","article-title":"New imidazole-2-ones and their 2-thione analogues as anticancer agents and CAIX inhibitors: synthesis, in silico ADME and molecular modeling studies","volume":"141","author":"Ibrahim","year":"2023","journal-title":"Bioorg. Chem."},{"issue":"9","key":"10.1016\/j.ejmech.2026.119324_bib40","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1039\/C3AN02166A","article-title":"Convenient detection of the thiol functional group using H\/D isotope sensitive Raman spectroscopy","volume":"139","author":"Bandyopadhyay","year":"2014","journal-title":"Analyst"},{"issue":"2","key":"10.1016\/j.ejmech.2026.119324_bib41","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.neuropharm.2005.02.007","article-title":"Design of antagonists for NMDA and AMPA receptors","volume":"49","author":"Bolshakov","year":"2005","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.ejmech.2026.119324_bib42","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/(SICI)1096-9861(20000619)422:1<123::AID-CNE8>3.0.CO;2-X","article-title":"Distribution of voltage\u2010gated sodium channel \u03b1\u2010subunit and \u03b2\u2010subunit mRNAs in human hippocampal formation, cortex, and cerebellum","volume":"422","author":"Whitaker","year":"2000","journal-title":"J. Comp. Neurol."},{"issue":"3","key":"10.1016\/j.ejmech.2026.119324_bib43","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1111\/j.1469-7793.1997.655ba.x","article-title":"Block of open channels of recombinant AMPA receptors and native AMPA\/Kainate receptors by adamantane derivatives","volume":"505","author":"Magazanik","year":"1997","journal-title":"J. Physiol."},{"issue":"3","key":"10.1016\/j.ejmech.2026.119324_bib44","doi-asserted-by":"crossref","first-page":"783","DOI":"10.3390\/biomedicines11030783","article-title":"The role of glutamate receptors in epilepsy","volume":"11","author":"Chen","year":"2023","journal-title":"Biomedicines"},{"issue":"7","key":"10.1016\/j.ejmech.2026.119324_bib45","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1021\/jm970682+","article-title":"Synthesis and anticonvulsant activity of 2 (3 H)-benzoxazolone and 2 (3 H)-benzothiazolone derivatives","volume":"41","author":"Ucar","year":"1998","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119324_bib46","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.775040","article-title":"Screening for activity against AMPA receptors among anticonvulsants\u2014focus on phenytoin","volume":"12","author":"Dron","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"5","key":"10.1016\/j.ejmech.2026.119324_bib47","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1021\/acs.jafc.5b04739","article-title":"Antioxidant activity\/capacity measurement. 1. Classification, physicochemical principles, mechanisms, and electron transfer (ET)-based assays","volume":"64","author":"Apak","year":"2016","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.ejmech.2026.119324_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.123470","article-title":"Statistical evaluation of DPPH, ABTS, FRAP, and Folin-Ciocalteu assays to assess the antioxidant capacity of lignins","volume":"233","author":"Rumpf","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ejmech.2026.119324_bib49","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ibneur.2022.08.003","article-title":"Pentylenetetrazole kindling-induced epilepsy rat models: insight on the severity state, a comparative study","volume":"13","author":"Ngoupaye","year":"2022","journal-title":"IBRO Neuroscience Reports"},{"issue":"2","key":"10.1016\/j.ejmech.2026.119324_bib50","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.neulet.2003.10.080","article-title":"Thiol redox state (TRS) and oxidative stress in the mouse hippocampus after pentylenetetrazol-induced epileptic seizure","volume":"357","author":"Patsoukis","year":"2004","journal-title":"Neurosci. Lett."},{"issue":"3","key":"10.1016\/j.ejmech.2026.119324_bib51","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0091-3057(02)01044-4","article-title":"Effect of Centella asiatica on pentylenetetrazole-induced kindling, cognition and oxidative stress in rats","volume":"74","author":"Gupta","year":"2003","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"3","key":"10.1016\/j.ejmech.2026.119324_bib52","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0223-5234(03)00012-6","article-title":"High throughput artificial membrane permeability assay for blood\u2013brain barrier","volume":"38","author":"Di","year":"2003","journal-title":"Eur. J. Med. Chem."},{"issue":"22","key":"10.1016\/j.ejmech.2026.119324_bib53","doi-asserted-by":"crossref","first-page":"13526","DOI":"10.1021\/acs.jmedchem.0c00272","article-title":"isoquinolin-4-one (GLPG1205), a unique GPR84 negative allosteric modulator undergoing evaluation in a phase II clinical trial","volume":"63","author":"Lab\u00e9gu\u00e8re","year":"2020","journal-title":"J. Med. Chem."},{"issue":"3","key":"10.1016\/j.ejmech.2026.119324_bib54","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1177\/201010581302200307","article-title":"Phenytoin: a guide to therapeutic drug monitoring","volume":"22","author":"Wu","year":"2013","journal-title":"Proc. Singapore Healthc."},{"key":"10.1016\/j.ejmech.2026.119324_bib55","series-title":"Neurotoxicity-New Advances","article-title":"Neurotoxicity and epileptogenesis","author":"Rubio","year":"2022"},{"issue":"7","key":"10.1016\/j.ejmech.2026.119324_bib56","doi-asserted-by":"crossref","first-page":"500","DOI":"10.3390\/bios12070500","article-title":"PC-12 cell line as a neuronal cell model for biosensing applications","volume":"12","author":"Oprea","year":"2022","journal-title":"Biosensors"},{"issue":"4","key":"10.1016\/j.ejmech.2026.119324_bib57","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1111\/bph.12534","article-title":"Properties of human brain sodium channel \u03b1\u2010subunits expressed in HEK293 cells and their modulation by carbamazepine, phenytoin and lamotrigine","volume":"171","author":"Qiao","year":"2014","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119324_bib58","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1093\/cvr\/cvr252","article-title":"Biology of cardiac sodium channel Nav1. 5 expression","volume":"93","author":"Rook","year":"2012","journal-title":"Cardiovasc. Res."},{"issue":"11","key":"10.1016\/j.ejmech.2026.119324_bib59","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1038\/s41594-024-01328-0","article-title":"Allosteric competition and inhibition in AMPA receptors","volume":"31","author":"Hale","year":"2024","journal-title":"Nat. Struct. Mol. Biol."},{"issue":"2","key":"10.1016\/j.ejmech.2026.119324_bib60","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1021\/ci800293n","article-title":"Validation of molecular docking programs for virtual screening against dihydropteroate synthase","volume":"49","author":"Hevener","year":"2009","journal-title":"J. J. o. c. i.; modeling"},{"issue":"5","key":"10.1016\/j.ejmech.2026.119324_bib61","first-page":"576","article-title":"Virtual screening and statistical analysis in the design of new caffeine analogues molecules with potential epithelial anticancer activity","volume":"24","author":"da Silva Costa","year":"2018"},{"issue":"Suppl 12","key":"10.1016\/j.ejmech.2026.119324_bib62","first-page":"S14","article-title":"Molecular docking studies of dithionitrobenzoic acid and its related compounds to protein disulfide isomerase: computational screening of inhibitors to HIV-1 entry","volume":"9","author":"Gowthaman","year":"2008"},{"issue":"6433","key":"10.1016\/j.ejmech.2026.119324_bib63","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1126\/science.aaw2999","article-title":"Molecular basis for pore blockade of human Na+ channel Nav1.2 by the \u03bc-conotoxin KIIIA","volume":"363","author":"Pan","year":"2019","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.ejmech.2026.119324_bib64","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/j.bmcl.2017.02.010","article-title":"Design, synthesis and in vitro cytotoxicity studies of novel \u03b2-carbolinium bromides","volume":"27","author":"Reddy","year":"2017","journal-title":"Bioorg. Med. Chem. Lett"},{"issue":"9","key":"10.1016\/j.ejmech.2026.119324_bib65","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1021\/jm00171a047","article-title":"Tricyclic heteroaromatic systems.[1] benzopyranopyrrol-4-ones and [1] benzopyrano-1, 2, 3-triazol-4-ones as benzodiazepine receptor ligands. Synthesis and structure-activity relationships","volume":"33","author":"Colotta","year":"1990","journal-title":"J. Med. Chem."},{"issue":"31","key":"10.1016\/j.ejmech.2026.119324_bib66","doi-asserted-by":"crossref","first-page":"6649","DOI":"10.1016\/j.tet.2004.05.096","article-title":"A selective reductive amination of aldehydes by the use of Hantzsch dihydropyridines as reductant","volume":"60","author":"Itoh","year":"2004","journal-title":"Tetrahedron"},{"issue":"2","key":"10.1016\/j.ejmech.2026.119324_bib67","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.bmcl.2007.11.072","article-title":"Design and optimization of imidazole derivatives as potent CXCR3 antagonists","volume":"18","author":"Du","year":"2008","journal-title":"Bioorg. Med. Chem. Lett"},{"issue":"5","key":"10.1016\/j.ejmech.2026.119324_bib68","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1021\/jo01343a025","article-title":"Reactions of phenylazirines with anilines","volume":"31","author":"Smolinsky","year":"1966","journal-title":"J. Org. Chem."},{"issue":"30","key":"10.1016\/j.ejmech.2026.119324_bib69","doi-asserted-by":"crossref","first-page":"7152","DOI":"10.1039\/D5OB00922G","article-title":"Synthesis of \u03b1-keto thioamides via oxidative thioamidation of \u03b1-amino carbonyls using hypervalent iodine under neat conditions","volume":"23","author":"Mondal","year":"2025","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.ejmech.2026.119324_bib70","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1039\/p19810002435","article-title":"Removal of toluene-p-sulphonyl groups from sulphonamides. Part 4. Synthesis of phenylglyoxal imine monomers","volume":"1","author":"McKay","year":"1981","journal-title":"Journal of the Chemical Society, Perkin Transactions"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426007695?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426007695?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T04:24:35Z","timestamp":1792643075000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523426007695"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":70,"alternative-id":["S0223523426007695"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.119324","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of 1,4-diaryl-1,3-dihydro-2H-imidazole-2-thione anticonvulsants integrating AMPA receptor antagonism, Nav1.2 channel blockade, redox modulation, and favorable pharmacokinetic properties","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.119324","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"119324"}}